Skip to main content
OpenTrials

Clinical trial condition

Pre-Exposure Prophylaxis of HIV Infection

Explore clinical trials studying Pre-Exposure Prophylaxis of HIV Infection. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Pre-Exposure Prophylaxis of HIV Infection trial results

Active, Not Recruiting

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

NCT04994509

Conditions
Pre-Exposure Prophylaxis of HIV Infection
Locations
  • Madibeng Centre for Research Brits, South Africa
  • Emavundleni Research Centre Cape Town, South Africa
  • Vuka Research Clinic Cape Town, South Africa
  • Desmond Tutu Health Foundation Clinical Trials Unit Cape Town, South Africa
View all 28 locations
View Trial Details
Active, Not Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

NCT06101342

Conditions
Pre-Exposure Prophylaxis of HIV Infection
Locations
  • UCLA Vine Street Clinic Los Angeles, California, United States
  • UCSD AntiViral Research Center (AVRC) San Diego, California, United States
  • University of Miami - Converge Miami Building Miami, Florida, United States
  • Johns Hopkins Medicine Institute for Clinical and Translational Research, Clinical Research Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

NCT04925752

Conditions
Pre-Exposure Prophylaxis of HIV Infection
Locations
  • UAB Sexual Health Research Clinic Birmingham, Alabama, United States
  • Loma Linda University Clinical Trial Center Clinic Loma Linda, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • UCLA CBAM Vine Street Clinic Los Angeles, California, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

NCT06101329

Conditions
Pre-Exposure Prophylaxis of HIV Infection
Locations
  • UAB, 1917 Research Clinic Birmingham, Alabama, United States
  • UCSD Antiviral Research Center (AVRC) San Diego, California, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Ponce de Leon Center Clinical Research Site Atlanta, Georgia, United States
View Trial Details

Related conditions